COVID-19 Pandemic vs. Pre-Pandemic Period: Changes in Hospital Admission Rates, Length of Stay, and In-Hospital Mortality of Common Neurologic Conditions
top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
crossref
doi
open access

Published: 04 May 2022

COVID-19 Pandemic vs. Pre-Pandemic Period: Changes in Hospital Admission Rates, Length of Stay, and In-Hospital Mortality of Common Neurologic Conditions

Alessandra R. De Leon, Criscely L. Go

Jose R. Reyes Memorial Medical Center, Philippines

journal of social and political sciences
pdf download

Download Full-Text Pdf

doi

10.31014/aior.1994.05.02.212

Pages: 62-67

Keywords: COVID-19, Admission Rate, Length of Stay, Mortality Rate, Cerebrovascular Diseases, CNS Infection, CNS Neoplasm, Seizure Disorders

Abstract

Background and Objective: COVID-19 pandemic caused massive adjustments to healthcare systems in the country. This study determined the change in hospital admission rates, length of hospital stay and in-hospital mortality of common (non-COVID related) neurologic conditions during the COVID-19 pandemic and pre-pandemic period. Methods: The study utilized a retrospective cross-sectional study of patients admitted under the Department of Neurology at Jose R. Reyes Memorial Medical Center from the period of March 2019 to March 2020 (pre-pandemic group), and April 2020 to April 2021 (COVID-19 pandemic). Admission rates, length of stay and in-hospital mortality were calculated for cerebrovascular diseases, CNS infections, CNS neoplasms and Seizure disorders. Results: There were 1090 admissions from April 2019 to March 2020 and 393 admissions from April 2020 to March 2021 with an over-all decline of 63%. During the pandemic, the duration of hospital stay was longer for CNS neoplasms. Duration of hospital stay for cerebrovascular disease, CNS infection, and seizure disorders were not significantly different. There was an increase in over-all in hospital mortality from 22.75% to 26.46% with significant increase in the case fatality rate of cerebrovascular diseases. Conclusion: We observed a large decline in the over-all admission rate and longer hospital stays. The over-all in-hospital mortality rate also increased during the pandemic period.

References

  1. Baum, A., & Schwartz, M. D. (2020). Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA, 324(1), 96–99. https://doi.org/10.1001/jama.2020.9972

  2. Butt, A. A., Kartha, A. B., Masoodi, N. A., Azad, A. M., Asaad, N. A., Alhomsi, M. U., Saleh, H., Bertollini, R., & Abou-Samra, A. B. (2020). Hospital admission rates, length of stay, and in-hospital mortality for common acute care conditions in COVID-19 vs. pre-COVID-19 era. Public health, 189, 6–11.

  3. COVID-19 in the Philippines.(2021, February 19). World Health Organization. https://www.who.int/philippines/emergencies/covid-19-in-the-philippines.

  4. COVID-19 pandemic: Latest situation in the Philippines – June 2021. (2021, June 30). Rappler. https://www.rappler.com/nation/covid-19-pandemic-latest-situation-in-the-philippines-june-2021.

  5. Rivera-Rodriguez, C., & Urdinola, B. P. (2020). Predicting Hospital Demand During the COVID-19 Outbreak in Bogotá, Colombia. Frontiers in public health, 8, 582706. https://doi.org/10.3389/fpubh.2020.582706

  6. WHO announces COVID-19 outbreak a pandemic. (2020, March 12). World Health Organization. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-apandemic.

  7. Zhang, Y., Geng, X., Tan, Y., Li, Q., Xu, C., Xu, J., Hao, L., Zeng, Z., Luo, X., Liu, F., & Wang, H. (2020). New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 127, 110195. https://doi.org/10.1016/j.biopha.2020.110195

bottom of page